Biomea Fusion, Inc. (BMEA) vs Rani Therapeutics Holdings, Inc. (RANI)
Biomea Fusion, Inc. and Rani Therapeutics Holdings, Inc. are both Biotechnology companies. Biomea Fusion, Inc. and Rani Therapeutics Holdings, Inc. are of similar size ($108.0M and $107.3M). Biomea Fusion, Inc. has the higher net margin (0.00% vs −597.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Biomea Fusion, Inc. leads on 7 and Rani Therapeutics Holdings, Inc. on 5.
Valuation
Profitability
| Metric | BMEA | RANI | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (652.78%) | 0.00% |
| Net margin | 0.00% | (596.97%) | 0.00% |
| Free cash flow margin | 0.00% | (402.83%) | 0.00% |
| Return on equity | (164.14%) | (155.24%) | (57.72%) |
| Return on assets | (59.14%) | (77.54%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack